Home › Conditions › Major Haemorrhage on Anticoagulation

Haematology

Major Haemorrhage on Anticoagulation

Life-threatening bleeding on anticoagulation requires immediate reversal using agent-specific antidotes. The major haemorrhage protocol (MHP) should be activated for haemodynamically significant bleeding. Restart timing depends on the bleeding site and control, anticoagulant and thrombotic risk. GI bleeding does not routinely require a 4–8-week delay.

BSH/NICE Anticoagulant Reversal Protocol

The pathway

Activate major haemorrhage protocol

Warfarin reversal

Dabigatran reversal

Rivaroxaban / Apixaban reversal; edoxaban needs specialist advice

LMWH reversal

Supportive haemostatic measures

Anticoagulation restart decision

Drugs

DrugDoseRouteNotes
4-factor PCC (Beriplex / Octaplex)25–50 IU/kgIVWarfarin/VKA reversal, or when a specific DOAC antidote is unavailable. Works within minutes. Give vitamin K alongside it for VKA reversal only — vitamin K does nothing for a DOAC. Repeat dosing is not recommended (Beriplex SmPC: not supported by clinical data).
Vitamin K (phytomenadione)5–10mgIVFor warfarin/VKA reversal only — not for DOAC bleeding. Co-administer with PCC; takes 6–12h to work, so PCC provides the immediate cover. IV preferred over oral in major bleeding.
Idarucizumab (Praxbind)5g (as 2 × 2.5g doses)IV- Specific dabigatran antidote - Give two consecutive 2.5g IV doses, each over 5–10 minutes, or as bolus injections - Rapid reversal; monitor bleeding and dabigatran-sensitive clotting tests
Andexanet alfa (Ondexxya)400–800mg bolus then 4–8mg/min for 120 minIVFactor Xa inhibitor antidote (rivaroxaban, apixaban). Dose depends on DOAC dose and timing. Specialist pharmacy involvement required. Obtain any drug-specific anti-Xa sample before treatment if it will help without delaying reversal. After andexanet, monitor haemostasis, rebleeding and thrombosis clinically; routine anti-Xa assays are unreliable.
Protamine sulphateUp to 1mg per 100 units UFH; adjust for timing (max 50mg per dose)IV slow- Stop heparin; confirm dose, route and timing with haematology/pharmacy - Give over 10 minutes; for UFH, recheck APTT after 5–15 minutes - Anaphylaxis risk: resuscitation equipment at bedside - LMWH reversal is partial; use the enoxaparin regimen above
Tranexamic acidMajor trauma: 1g over 10 minutes, then 1g over 8h; selected head injury: 2g bolusIVAdjunct for traumatic or surgical haemorrhage. AVOID in haematuria (risk of clot retention) and subarachnoid haemorrhage without trauma. - Head injury: age ≥16, GCS ≤12, no suspected active extracranial bleeding: consider 2g IV within 2h, before imaging - Major trauma with bleeding: start within 3h; later only if hyperfibrinolysis is demonstrated - TXA does not replace anticoagulant reversal; check any pre-hospital dose

When to escalate

Reference: BSH Guideline on the Use of Anticoagulant Reversal Agents 2022 / NICE NG196

Practise and explore

Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.

Ready for your next shift

Get it on your phone

Free, offline, no account.

Download bleep oncall

The current iPhone release, on the App Store.

Made between shifts

Keep bleep brewing.

Free to use. Ad-free by choice. If bleep has helped you through a shift, you can support what comes next.

Buy me a coffee

A small thank you. Always optional.